Robeco Institutional Asset Management B.V. Sells 214 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Robeco Institutional Asset Management B.V. lessened its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB) by 0.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 196,142 shares of the electronics maker’s stock after selling 214 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.21% of Dolby Laboratories worth $15,319,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the stock. Harbor Capital Advisors Inc. raised its holdings in Dolby Laboratories by 5.6% in the 4th quarter. Harbor Capital Advisors Inc. now owns 2,571 shares of the electronics maker’s stock valued at $201,000 after acquiring an additional 136 shares in the last quarter. First Horizon Advisors Inc. raised its holdings in Dolby Laboratories by 22.7% in the 3rd quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock valued at $60,000 after acquiring an additional 146 shares in the last quarter. Fifth Third Bancorp raised its holdings in Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock valued at $28,000 after acquiring an additional 163 shares in the last quarter. Glenmede Trust Co. NA raised its holdings in Dolby Laboratories by 3.5% in the 3rd quarter. Glenmede Trust Co. NA now owns 5,376 shares of the electronics maker’s stock valued at $411,000 after acquiring an additional 182 shares in the last quarter. Finally, Blue Trust Inc. raised its holdings in Dolby Laboratories by 14.7% in the 4th quarter. Blue Trust Inc. now owns 1,587 shares of the electronics maker’s stock valued at $121,000 after acquiring an additional 203 shares in the last quarter. Institutional investors own 58.56% of the company’s stock.

Analysts Set New Price Targets

DLB has been the subject of a number of recent research reports. StockNews.com cut Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a report on Friday. Rosenblatt Securities reissued a “buy” rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Thursday. Finally, Barrington Research reissued an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Monday, January 27th.

Dolby Laboratories Price Performance

NYSE DLB opened at $83.63 on Friday. The firm has a market cap of $7.98 billion, a PE ratio of 30.75 and a beta of 0.98. Dolby Laboratories, Inc. has a one year low of $66.35 and a one year high of $89.66. The stock’s 50 day simple moving average is $79.35 and its 200 day simple moving average is $75.76.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Tuesday, February 11th. This represents a $1.32 dividend on an annualized basis and a yield of 1.58%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.53%.

Insider Buying and Selling

In related news, CEO Kevin J. Yeaman sold 50,000 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $80.54, for a total transaction of $4,027,000.00. Following the sale, the chief executive officer now directly owns 83,721 shares in the company, valued at $6,742,889.34. This represents a 37.39 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ryan Nicholson sold 10,500 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total value of $841,890.00. Following the completion of the transaction, the chief accounting officer now owns 24,364 shares in the company, valued at $1,953,505.52. The trade was a 30.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 135,917 shares of company stock worth $10,877,739 in the last three months. Insiders own 38.39% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.